Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer
- 1 September 1991
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 28 (5) , 405-407
- https://doi.org/10.1007/bf00685698
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.Journal of Clinical Oncology, 1989
- PHASE-II TRIAL OF MITOMYCIN, VINDESINE, AND HEXAMETHYLMELAMINE IN METASTATIC NON-SMALL CELL BRONCHOGENIC-CARCINOMA1986
- Therapy with cisplatin and etoposide for non-small-cell lung cancer.1986
- TRIAL OF THE COMBINATION OF MITOMYCIN, VINDESINE, AND CISPLATIN IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG-CANCER1986
- Vindesine and mitomycin in the treatment of advanced non-small cell lung cancer: a Southeastern Cancer Study Group Trial.1986
- Cis-platinum and vindesine in combination in the treatment of non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- RANDOMIZED TRIAL COMPARING VINDESINE PLUS CISPLATIN WITH VINBLASTINE PLUS CISPLATIN IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER, WITH AN ANALYSIS OF METHODS OF RESPONSE ASSESSMENT1985
- Reporting results of cancer treatmentCancer, 1981
- VP-16-213 CHEMOTHERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF LUNG1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958